Skip to content

Armada B2120-060Recalls & reported problems

Abbott Vascular Inc. · Armada 35 PTA Catheter 12 mm x 60 mm x 135 cm / Over-The-Wire · Class 2

All models of Armada (213)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 08717648155567), received between Mar 27, 2021 and Mar 30, 2026 — classified as 1 injury, 5 malfunctions.

The most frequently reported specific device problem is “Material Rupture” (5 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Rupture5
  • Improper or Incorrect Procedure or Method3
  • Difficult to Remove1
  • Entrapment of Device1
  • Material Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions5
  • Insufficient Information1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 30, 2026Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE PERFORMED WAS TO TREAT A RESTENOSIS, MODERATELY CALCIFIED, HEAVILY TORTUOUS ATRIOVENTRICULAR FISTULA THAT IS 90% STENOSED. THE 12.0X60MM ARMADA 35 BALLOON DILATATION CATHETER (BDC) WAS INFLATED THE FIRST TIME TO 8 ATMOSPHERES (ATM); HOWEVER THE BALLOON RUPTURED. A NEW 12.0X60MM ARMADA 35 BDC WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24712575 ↗
  • MalfunctionMay 21, 2024Material Rupture; Material Rupture

    IT WAS REPORTED THE PROCEDURE WAS TO TREAT A LESION IN THE MODERATELY CALCIFIED RIGHT ILIAC ARTERY. THE 12.0X60MM ARMADA 35 BALLOON DILATATION CATHETER WAS ADVANCED TO THE TARGET LESION HOWEVER DURING THE FIRST INFLATION THE BALLOON RUPTURED AT 8 ATMOSPHERES. THE BDC WAS REMOVED WITHOUT ISSUE. A SAME SIZE ARMADA 35 WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE AND NO ADVERSE PATIENT EFFECTS. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19358165 ↗
  • MalfunctionAug 21, 2023Difficult to Remove; Improper or Incorrect Procedure or Method; Difficult to Remove; Improper or Incorrect Procedure or Method

    IT WAS REPORTED THAT THE 12X60MM ARMADA 35 BALLOON DILATATION CATHETER (BDC) YELLOW PROTECTIVE SHEATH COULD NOT BE REMOVED FROM THE DEVICE. ANOTHER UNSPECIFIED BALLOON WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO PATIENT INVOLVEMENT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17586091 ↗
  • MalfunctionMar 8, 2022Material Rupture; Improper or Incorrect Procedure or Method; Material Rupture; Improper or Incorrect Procedure or Method

    PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT PRESENTED WITH A LEFT ILIAC VEIN, 100% RESTENOSED LESION THAT HAD BEEN PREVIOUSLY TREATED WITH AN UNSPECIFIED STENT. BALLOON ANGIOPLASTY WAS SUCCESSFULLY PERFORMED USING TWO ARMADA 35 CATHETERS. TWO ADDITIONAL ARMADA CATHETERS WERE SUCCESSFULLY ADVANCED. BOTH DEVICE BALLOONS HAD RUPTURED BELOW RATED BURST PRESSURE. THE RUPTURES WERE SUSPECTED DUE TO THE PREVIOUSLY IMPLANTED STENT STRUTS OF THE UNSPECIFIED STENT. THE DEVICES WERE SUCCESSFULLY WITHDRAWN. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13698898 ↗
  • MalfunctionMar 8, 2022Material Rupture; Improper or Incorrect Procedure or Method; Material Rupture; Improper or Incorrect Procedure or Method

    PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2022, THE PATIENT PRESENTED WITH A LEFT ILIAC VEIN, 100% RESTENOSED LESION THAT HAD BEEN PREVIOUSLY TREATED WITH AN UNSPECIFIED STENT. BALLOON ANGIOPLASTY WAS SUCCESSFULLY PERFORMED USING TWO ARMADA 35 CATHETERS. TWO ADDITIONAL ARMADA CATHETERS WERE SUCCESSFULLY ADVANCED. BOTH DEVICE BALLOONS HAD RUPTURED BELOW RATED BURST PRESSURE. THE RUPTURES WERE SUSPECTED DUE TO THE PREVIOUSLY IMPLANTED STENT STRUTS OF THE UNSPECIFIED STENT. THE DEVICES WERE SUCCESSFULLY WITHDRAWN. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13698725 ↗
  • InjuryMar 27, 2021Entrapment of Device; Material Rupture; Material Separation; Entrapment of Device; Material Rupture; Material Separation

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A COMMON ILIAC ARTERY. A 12X40MM ARMADA 35 BALLOON WAS ADVANCED TO THE LESION WITHOUT RESISTANCE. ONCE AT THE LESION, THE BALLOON WAS INFLATED ONCE AT 3-4 ATMOSPHERES (ATM) AND RUPTURED CIRCUMFERENTIALLY. THE DEVICE WAS WITHDRAWN WITHOUT ISSUE. THEN A 12X60MM ARMADA 35 BALLOON WAS ADVANCED TO THE LESION WITHOUT RESISTANCE. ONCE AT THE LESION, THE BALLOON WAS INFLATED ONCE AT 3-4 ATMOSPHERES (ATM) AND RUPTURED CIRCUMFERENTIALLY. THE DEVICE WAS ATTEMPTED TO BE REMOVED BUT MET RESISTANCE WITH THE ANATOMY AND COULD NOT BE REMOVED COMPLETELY. THEREFORE SURGICAL INTERVENTION WAS PERFORMED TO SUCCESSFULLY REMOVE THE DEVICE. A NON-ABBOTT BALLOON WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS A CLINICALLY SIGNIFICANT DELAY REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Insufficient Information

    MAUDE report 11578883 ↗

Other CATHETER, PERCUTANEOUS devices

All CATHETER, PERCUTANEOUS devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page